Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

Summary

The study is planned to evaluate the therapeutic efficacy and safety of XC8, film-coated tablets, in the treatment of dry non-productive cough on the background of acute respiratory infections in children from 6 to 17 years compared with placebo.

Timeline

Start

2023-12-04

Primary completion

2025-12-31

Completion

2025-12-31

Drugs

Indications